Hui-Li Wong

Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei

Michael P Flood, Joseph C Kong, Toan Pham, Peadar S Waters, Mikael Soucisse, Robert Ramsay, Hui-Li Wong, Catherine Mitchell, Michael Michael, Jacob J McCormick, Satish K Warrier, Tim Akhurst, Alexander G Heriot

Journal article  |  2022  |  EJSO

BACKGROUND: Pseudomyxoma peritonei (PMP) is a rare clinical entity, commonly derived from a mucin-producing tumour of the appendix..

Evaluating the utility of fluorine-18 fluorodeoxyglucose (18F-FDG)-positron emission tomography (PET)/ computed tomography (CT) scan in cancer of unknown primary.

Tharani Sivakumaran, Anthony Cardin, Jason Callahan, Hui-Li Wong, Richard Tothill, Rodney Hicks, Linda R Mileshkin

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

3062 Background: Cancer of unknown primary (CUP) represents a heterogeneous group of metastatic tumours where standardized diagno..

Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: An application of the TARGET-TP score.

Kate Burbury, Marliese Alexander, Samuel J Harris, Craig Underhill, Javier Torres, Sharad Sharma, Nora Lee, Hui-Li Wong, Richard Wilhelm Eek, Michael Michael, Jeanne Tie, Jennifer Rogers, Alexander Graham Heriot, David Ball, Michael Patrick MacManus, Rory Wolfe, Benjamin J Solomon

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

12116 Background: Interventional trials applying risk models for targeted-thromboprophylaxis (TP) for ambulatory cancer patients ..

Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma

Alexander Grogan, Benjamin Loveday, Michael Michael, Hui-Li Wong, Peter Gibbs, Benjamin Thomson, Belinda Lee, Hyun Soo Ko

Journal article  |  2022  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Computed tomography (CT) is the first-line staging imaging modality for pancreatic ductal adenocarcinoma (PDAC) which ..

Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial

M Alexander, SJ Harris, C Underhill, J Torres, S Sharma, N Lee, H Wong, R Eek, M Michael, J Tie, J Rogers, A Heriot, D Ball, M MacManus, R Wolfe, B Solomon, K Burbury

Conference Proceedings  |  2022  |  THROMBOSIS RESEARCH

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the r..

Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET-TP score

M Alexander, SJ Harris, C Underhill, J Torres, S Sharma, N Lee, H Wong, R Eek, M Michael, J Tie, J Rogers, A Heriot, D Ball, M MacManus, R Wolfe, B Solomon, K Burbury

Conference Proceedings  |  2022  |  THROMBOSIS RESEARCH

The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the r..

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

A Jalali, G Gard, S Banks, C Dunn, HL Wong, R Wong, M Lee, L Gately, M Loft, JD Shapiro, S Kosmider, J Tie, S Ananda, JM Yeung, R Jennens, B Lee, J McKendrick, L Lim, A Khattak, P Gibbs

Journal article  |  2022  |  CURRENT PROBLEMS IN CANCER

For patients with refractory metastatic colorectal cancer (mCRC) treatment with Trifluridine/Tipiracil, also known as TAS-102, imp..

Long-term survival outcomes following resection of lung metastases (LM) from a colorectal primary.

Sangeetha Ramanujam, Catherine Dunn, Phillip Antippa, Suzanne Kosmider, Yat Hang To, Margaret Lee, Vanessa Wong, Susan Caird, Jeremy David Shapiro, Joseph James McKendrick, Hui-Li Wong, Brigette Ma, Stephanie Hui-Su Lim, Javier Torres, Allan Solomon Zimet, Belinda Lee, Peter Gibbs

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

50 Background: Liver metastatectomy in oligometastatic colorectal cancer (CRC) can result in long-term disease control1. The bene..

Integrative analysis of KRAS-wildtype pancreatic ductal adenocarcinoma reveals unique similarities to extrahepatic cholangiocarcinoma.

Erica S Tsang, James T Topham, Joanna Karasinska, Steve Kalloger, Veronika Csizmok, Laura Williamson, Hui-Li Wong, Grainne M O'Kane, Jonathan M Loree, Faiyaz Notta, Oliver F Bathe, Patricia A Tang, Rachel Anne Goodwin, Jennifer J Knox, Steven Gallinger, Janessa J Laskin, Marco A Marra, Steven JM Jones, David F Schaeffer, Daniel John Renouf

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

587 Background: Oncogenic driver mutations in KRAS represent a hallmark genomic event in approximately 90% of pancreatic adenocar..

Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer

Chia Yuen Chong, Azim Jalali, Hui Li Wong, Matthew Loft, Rachel Wong, Margaret Lee, Lucy Gately, Wei Hong, Jeremy Shapiro, Suzanne Kosmider, Jeannie Tie, Sumitra Ananda, Justin M Yeung, Brigette Ma, Matthew Burge, Ross Jennens, Ben Tran, Belinda Lee, Lionel Lim, Andrew Dean, et al.

Journal article  |  2022  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: RAS mutation testing now routinely informs the optimal management of metastatic colorectal cancer (mCRC), specifically..